|
Bliss GVS Pharma Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
1648.40 Cr.
|
P/BV
|
1.63
|
Book Value (Rs.)
|
95.74
|
|
52 Week High/Low (Rs.)
|
186/103
|
FV/ML
|
1/1
|
P/E(X)
|
19.55
|
|
Bookclosure
|
25/07/2024
|
EPS (Rs.)
|
7.99
|
Div Yield (%)
|
0.32
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 125.64 | 146.07 | 106.07 | 127.76 | 104.13 |
| | | | | | |
| Net CashFlow From Operating Activities | 105.91 | 152.45 | 34.31 | 135.48 | 63.97 |
| Net Cash Used In Investing Activities | -75.44 | -132.82 | -7.75 | -92.98 | -46.99 |
| Net Cash Used From Financing Activities | -30.34 | -20.89 | -24.94 | -23.73 | -20.80 |
| Foreign Exchange Gains / Losses | 0.10 | -0.15 | 1.40 | -9.92 | 1.61 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.23 | -1.42 | 3.02 | 8.85 | -2.21 |
| Cash And Cash Equivalents Begin of Year | 23.59 | 25.01 | 21.99 | 13.13 | 15.34 |
| Cash And Cash Equivalents End Of Year | 23.82 | 23.59 | 25.01 | 21.99 | 13.13 |
